确定成人带状疱疹减毒活疫苗的最优接种策略
研究采用随机动态规划模拟50至100岁男女队列,评估每年接种或推迟接种带状疱疹疫苗的决策。在每质量调整生命年10万美元支付意愿下,女性最优接种年龄为66至77岁,男性为66至74岁;若有加强疫苗,最优接种年龄提前,且女性年龄范围更宽。
要点
- 女性最优接种年龄为66至77岁,男性为66至74岁(支付意愿每QALY 10万美元)。
- 若有加强疫苗,最优接种年龄提前,女性年龄范围宽于男性。
- 该研究首次用随机动态规划探讨任何疫苗第二剂问题。
核心结论
- 在每质量调整生命年10万美元支付意愿下,女性最优策略为66至77岁接种,男性为66至74岁。
- 若有加强疫苗,最优接种年龄提前,且女性年龄范围宽于男性。
研究设计与样本
- 模拟男性和女性队列,使用随机动态规划评估50至100岁每年接种或推迟接种的决策。
- 若推迟,队列面临带状疱疹风险;若发生带状疱疹,则承受该年龄典型感染(含并发症)的费用和质量调整生命年损失。
- 将模型扩展至考虑加强疫苗可用的情形,并进行概率敏感性分析检查模型稳健性。
主要发现
- 女性最优接种年龄为66至77岁,男性为66至74岁(支付意愿每QALY 10万美元)。
- 有加强疫苗时最优接种年龄提前,女性年龄范围宽于男性。
- 该研究首次检验带状疱疹疫苗确切接种时间,并首次用随机动态规划探讨任何疫苗第二剂问题。
关键数值与推荐
- 支付意愿阈值为每质量调整生命年10万美元。
- 女性最优接种年龄66至77岁,男性66至74岁。
- 有加强疫苗时最优接种年龄提前。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The optimal strategy for the vaccinating against herpes zoster (HZ) vaccine remains unknown. Cost-effectiveness analyses provide insight to the most cost-effective age groups but results vary across studies. The optimal strategy is important given that vaccine efficacy and duration vary depending on vaccination age. Therefore, small changes from the optimal age can affect long-term outcomes and produce sub-optimal results. The objective of this research was to determine the optimal timing policy for HZ vaccination. We simulated cohorts of men and women and use stochastic dynamic programming to evaluate the decision to vaccinate or defer each year from age 50 to 100. If the decision was to defer, the cohort risked developing HZ. If HZ occurred, the cohort was subjected to cost and quality-adjusted life year (QALY) loss for a typical HZ infection (including complications) at that age. If HZ did not occur, the decision was evaluated at the next age. Then, we extend the model to consider the case in which a booster vaccine is available. A set of probabilistic sensitivity analyses were conducted to check model robustness. Results show the optimal policy for women is to vaccinate between ages 66 and 77, and for men between ages 66 and 74, assuming a willingness to pay (WTP) of $100,000 per QALY. It becomes optimal to vaccinate earlier if a booster vaccine is available, and women have a wider range of ages than men. This research is the first to examine exactly when the HZ vaccine should be administered. It is also the first study, to our knowledge, that used stochastic dynamic programming to examine the question of a second dose for any vaccine. This research provides the first simple policy on when to vaccinate and re-vaccinate against HZ.
引用
- Harvey MJ, Denton BT, Prosser LA, et al. Determining the optimal strategy for the live-attenuated herpes zoster vaccine in adults. Vaccine. 2018. PMID: 30031663. doi:10.1016/j.vaccine.2018.06.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。